UM
Adjunctive minocycline for major mental disorders: A systematic review
Zheng,Wei1; Zhu,Xiao Min2; Zhang,Qing E.3; Cheng,Gen3; Cai,Dong Bin4; He,Jie5; Ng,Chee H.6; Ungvari,Gabor S.7,8; Peng,Xiao Jiang1; Ning,Yu Ping1; Xiang,Yu Tao9
2019-10-01
Source PublicationJournal of Psychopharmacology
ISSN0269-8811
Volume33Issue:10Pages:1215-1226
AbstractObjectives: This meta-analysis of randomized controlled trials (RCTs) examined the efficacy and safety of minocycline for three major mental disorders: schizophrenia, bipolar disorder and major depressive disorder (MDD). Methods: A systematic literature search of major electronic databases was conducted. Meta-analysis of clinical efficacy as defined by the respective studies, all-cause discontinuation, adverse drug reactions (ADRs) with standardized mean difference (SMD) and risk ratios (RRs) and their 95% confidence intervals (CI) was conducted using random-effects model. Quality assessment was performed with the Jadad scale and Cochrane risk of bias. Results: Sixteen RCTs (n=1357) on minocycline (50–300 mg/day) for schizophrenia (13 RCTs, n=1196), bipolar depression (1 RCT, n=49), and MDD (2 RCTs, n=112) were analyzed separately by diagnosis. Twelve RCTs mentioned randomized allocation specifically; the weighted Jadad scores were 4.0. Adjunctive minocycline outperformed placebo in improving total psychopathology [SMD: −0.45 (95%CI: −0.73, −0.16), p=0.002; I=77%], positive [SMD: −0.15 (95%CI: −0.28, −0.02), p=0.02; I=0%], negative [SMD: −0.62 (95%CI: −0.95, −0.28), p=0.0003; I=85%] and general psychopathology scores [SMD: −0.28 (95%CI: −0.53, −0.03), p=0.03; I=59%] in schizophrenia. Minocycline showed no significant effect on depressive and manic symptoms in both bipolar depression and MDD. Minocycline caused significantly less headache (p=0.02, number-needed-to-harm=14, 95%CI=5–14) than placebo in schizophrenia. All-cause discontinuation and other ADRs were similar between minocycline and placebo in each diagnostic category. Conclusion: In this meta-analysis, adjunctive minocycline appeared to be efficacious and safe for schizophrenia. However, the efficacy of adjunctive minocycline for bipolar depression or MDD could not be demonstrated. Review registration: PROSPERO: CRD42018102483
Keywordbipolar disorder major depressive disorder meta-analysis Minocycline negative symptoms schizophrenia
DOI10.1177/0269881119858286
URLView the original
Language英語English
Scopus ID2-s2.0-85068898992
Fulltext Access
Citation statistics
Cited Times [WOS]:12   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Affiliation1.The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital),Guangzhou,China
2.Suzhou Guangji Hospital,the Affiliated Guangji Hospital of Soochow University,Suzhou,China
3.The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders,Beijing Anding Hospital,Capital Medical University $and$ the Advanced Innovation Center for Human Brain Protection,Capital Medical University,Beijing,China
4.Shenzhen Traditional Chinese Medicine Hospital,Shenzhen,China
5.The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,China
6.Department of Psychiatry,University of Melbourne,Melbourne,Australia
7.The University of Notre Dame Australia,Fremantle,Australia
8.Division of Psychiatry,School of Medicine,University of Western Australia,Perth,Australia
9.Unit of Psychiatry,Faculty of Health Sciences,University of Macau,Macao
Recommended Citation
GB/T 7714
Zheng,Wei,Zhu,Xiao Min,Zhang,Qing E.,et al. Adjunctive minocycline for major mental disorders: A systematic review[J]. Journal of Psychopharmacology,2019,33(10):1215-1226.
APA Zheng,Wei,Zhu,Xiao Min,Zhang,Qing E.,Cheng,Gen,Cai,Dong Bin,He,Jie,Ng,Chee H.,Ungvari,Gabor S.,Peng,Xiao Jiang,Ning,Yu Ping,&Xiang,Yu Tao.(2019).Adjunctive minocycline for major mental disorders: A systematic review.Journal of Psychopharmacology,33(10),1215-1226.
MLA Zheng,Wei,et al."Adjunctive minocycline for major mental disorders: A systematic review".Journal of Psychopharmacology 33.10(2019):1215-1226.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zheng,Wei]'s Articles
[Zhu,Xiao Min]'s Articles
[Zhang,Qing E.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zheng,Wei]'s Articles
[Zhu,Xiao Min]'s Articles
[Zhang,Qing E.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zheng,Wei]'s Articles
[Zhu,Xiao Min]'s Articles
[Zhang,Qing E.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.